FacebookTwitterYoutubeInstagramGoogle Plus

Luke Dow


Luke Dow is an assistant professor of Biochemistry in Medicine at Weill Cornell Medicine in New York City. Dow completed his PhD in Melbourne, Australia, before joining the laboratory of Professor Scott Lowe for his postdoctoral work in 2008, where he developed new systems to interrogate gene function in the mouse, including the first application of inducible in vivo CRISPR-based genome editing tools. His lab at Weill Cornell is focused on understanding the biology of colorectal cancer (CRC), and developing new therapeutic approaches to treat this disease. They build tailored pre-clinical models—based on genetic alterations frequently observed in human CRC—to investigate how genetic alterations influence the onset, progression and therapeutic response of CRC.

Past Programs Featuring Luke Dow